Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017

Details for Mechanism ID: 17692
Country/Region: Haiti
Year: 2016
Main Partner: Pathfinder International
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Strategic Information (HVSI) $0
Testing: HIV Testing and Counseling (HVCT) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $0
Treatment: Adult Treatment (HTXS) $0
Treatment: Pediatric Treatment (PDTX) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV By PEP service provision (related to sexual violence services provided) 2017 14
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 1
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2017 14
GEND_GBV Number of people receiving post-GBV care 2017 15
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 3,303
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 3,303
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 44,726
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 32,388
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 83,720
HTS_TST Service Delivery Point (Facility): Inpatient 2017 293
HTS_TST Service Delivery Point (Facility): Pediatric 2017 6,604
HTS_TST Service Delivery Point (Facility): PMTCT 2017 42,949
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 1,156
HTS_TST Service Delivery Point (Facility): VCT 2017 32,719
HTS_TST Sum of Aggregated Age/Sex <15 2017 6,606
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 77,114
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 83,720
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 49
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 49
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 973
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 712
OVC_SERV By Aggregated Age/Sex: <18 Female 2017 4,781
OVC_SERV By Aggregated Age/Sex: <18 Male 2017 4,411
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2017 9,192
PMTCT_ART Already on ART at beginning of current pregnancy 2017 305
PMTCT_ART New on ART 2017 425
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 42,949
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 433
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 293
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 17
PMTCT_EID Number of infants with a positive virological test result within 2 months of birth 2017 24
PMTCT_EID Sum of Infant Age disaggregates 2017 726
PMTCT_STAT By: Known positives at entry 2017 344
PMTCT_STAT By: Number of new positives identified 2017 426
PMTCT_STAT Number of new ANC and L&D clients 2017 44,433
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 42,949
PMTCT_STAT Sum of Positives Status disaggregates 2017 770
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 4
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 86
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 2
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 61
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 153
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 153
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 115
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 36
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 115
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 14
TB_SCREENDX Screen Result: Screened Positive for TB 2017 115
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 3,025
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 2,015
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 160
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 109
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 5,309
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 34
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 656
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 23
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 441
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 1,154
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 1,382
TX_CURR Aggregated Age/Sex: <15 Female 2017 160
TX_CURR Aggregated Age/Sex: <15 Male 2017 109
TX_CURR Aggregated Age/Sex: 15+ Female 2017 3,025
TX_CURR Aggregated Age/Sex: 15+ Male 2017 2,015
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 5,309
TX_CURR Sum of Aggregated Age/Sex <15 2017 269
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 5,040
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 5,309
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 40
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 40
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 656
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 475
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,211
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,211
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 5,309
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 3,981
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 123
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 81
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 2,266
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 1,511
TX_PVLS Numerator: Indication: Routine 2017 3,584
TX_PVLS Numerator: Indication: Targeted 2017 397
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 160
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 109
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 3,025
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 2,015
TX_PVLS_den Denominator: Indication: Routine 2017 4,776
TX_PVLS_den Denominator: Indication: Targeted 2017 533
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 38
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 29
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 795
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 462
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 1,324
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 1,618
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 49
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 32
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 970
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 567